Janux Therapeutics, Inc. (JANX) Tops Q3 EPS by 22c

Janux Therapeutics, Inc. (NASDAQ: JANX) reported Q3 EPS of ($0.25), $0.22 better than the analyst estimate of ($0.47).

For earnings history and earnings-related data on Janux Therapeutics, Inc. (JANX) click here.

You May Also Be Interested In

• NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
• GitLab Inc (GTLB) Tops Q2 EPS by 7c, Beats on Revenue
• Dell Technologies (DELL) Tops Q2 EPS by $2.17, Offers Guidance